Actelion in $360M settlement - San Francisco Business Times
Jean-Paul Clozel | Financial Times
Börsengang zahlt sich für Ehepaar Clozel aus | FM1Today
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion-Gründer erhalten Preis der Vereinigung Starkes Basel
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
Jean-Paul Clozel
Idorsia : Transforming the Horizons of Therapeutic Options | Insights Care
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Jean-Paul Clozel
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Idorsia 'cuts Actelion umbilical cord', says cash pile suffices
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Pharma. Neues Pharmaunternehmen von Jean-Paul Clozel auf Kurs.
Idorsia, a small company with a big portfolio says Martine Clozel
Jean-Paul Clozel
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
